Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Merck
Moodys
US Army
Teva
Citi
Novartis
Queensland Health
McKinsey
Chubb

Generated: January 18, 2018

DrugPatentWatch Database Preview

Dyphylline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dyphylline and what is the scope of dyphylline freedom to operate?

Dyphylline
is the generic ingredient in four branded drugs marketed by Teva, Savage Labs, and Mylan Speciality Lp, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for dyphylline.
Summary for dyphylline
Medical Subject Heading (MeSH) Categories for dyphylline

US Patents and Regulatory Information for dyphylline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs DILOR dyphylline TABLET;ORAL 084514-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Savage Labs DILOR-400 dyphylline TABLET;ORAL 084751-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NEOTHYLLINE dyphylline ELIXIR;ORAL 007794-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NEOTHYLLINE dyphylline TABLET;ORAL 007794-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NEOTHYLLINE dyphylline TABLET;ORAL 007794-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NEOTHYLLINE dyphylline INJECTABLE;INJECTION 009088-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp LUFYLLIN dyphylline TABLET;ORAL 084566-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp LUFYLLIN dyphylline TABLET;ORAL 084566-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Baxter
AstraZeneca
Chubb
Johnson and Johnson
Cantor Fitzgerald
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot